IntoCell Enters into Development and License Option Agreement with ADC Therapeutics
Go back to IntoCell Enters into Development and License Option Agreement with ADC Therapeutics| ADC TELECOMM (NYSE: ADCT) | Delayed: 1.50 +0.06 (4.17%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.44 | 52 Week High | $12.76 | |||
| Open | $1.45 | 52 Week Low | $5.18 | |||
| Day High | $1.54 | P/E | 1.92 | |||
| Day Low | $1.43 | EPS | $0.78 | |||
| Volume | 246,784 | |||||



